Figure 2.
Figure 2. Activation of the minimal human EPO promoter by Wt1(–KTS) in U2OS cells. Relative luciferase activities measured in lysates of human osteosarcoma U2OS cells. The cells were transiently transfected with a pGL2 reporter vector containing the minimal human EPO promoter either as wild-type (p117, top 3 boxes) or with a mutated (mutant C in Table 1) Wt1(–KTS) binding site (mut p117; bottom 3 boxes). Wt1 expression constructs encoding different splice variants—Wt1(–KTS) or Wt1(+KTS)—were cotransfected along with a cytomegalovirus promoter–driven β-galactosidase expression vector for normalization of transfection efficiencies. pCB6+ is the empty expression vector. Values are shown as mean ± SEM of 5 experiments, each performed in duplicate. *P < .05; ANOVA.

Activation of the minimal human EPO promoter by Wt1(–KTS) in U2OS cells. Relative luciferase activities measured in lysates of human osteosarcoma U2OS cells. The cells were transiently transfected with a pGL2 reporter vector containing the minimal human EPO promoter either as wild-type (p117, top 3 boxes) or with a mutated (mutant C in Table 1) Wt1(–KTS) binding site (mut p117; bottom 3 boxes). Wt1 expression constructs encoding different splice variants—Wt1(–KTS) or Wt1(+KTS)—were cotransfected along with a cytomegalovirus promoter–driven β-galactosidase expression vector for normalization of transfection efficiencies. pCB6+ is the empty expression vector. Values are shown as mean ± SEM of 5 experiments, each performed in duplicate. *P < .05; ANOVA.

Close Modal

or Create an Account

Close Modal
Close Modal